In this video, Eric Klein, MD, discusses a study evaluating the 17-gene Oncotype DX Genomic Prostate Score assay in African American and Caucasian American men.
In this video, Eric Klein, MD, of Glickman Urological and Kidney Institute at Cleveland Clinic discusses a study he presented at the 2020 American Urological Association Virtual Experience. The study evaluated the 17-gene Oncotype DX Genomic Prostate Score assay in African American and Caucasian American men.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.